<DOC>
	<DOCNO>NCT02905695</DOCNO>
	<brief_summary>The aim placebo-controlled clinical trial ass effectiveness local infiltration analgesic Chirocaïne® perineal pain episiotomy first-degree tear . The pain intensity measure immediate postpartum period use numerical rating scale ( NRS ) follow time : H2 , H4 , H8 , H12 , H24 , H36 , H48 rest , defecation activity . The safety Chirocaïne® patient satisfaction also evaluate time .</brief_summary>
	<brief_title>Post-partum Perineal Pain - Chirocaine®</brief_title>
	<detailed_description />
	<mesh_term>Levobupivacaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Patients age 1845 year Single pregnancy . Vaginal normal birth cephalic presentation assist vaginal delivery vacuum extractor . Patients mediolateral episiotomy firstdegree perineal tear , epidural analgesia . Patients affiliate national insurance scheme Patients give write consent Patient speaking , reading , write French . Multiple pregnancy . Breech delivery instrumental delivery forceps spatula . Intact perineum . No epidural analgesia . Patient represent contraindication local anesthetic , severe arterial hypotension . Previous tear require suture .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Post-partum Perineal pain</keyword>
	<keyword>Episiotomy</keyword>
	<keyword>First-degree tear</keyword>
</DOC>